GW&K Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

GW&K Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,080	Closed	-$48K	–	925
2023 Q1	$48K	Sell	1,080 -633,621	-100%	-$26.6M	﹤0.01%	350
2022 Q4	$13.7M	Sell	634,701 -9,091	-1%	-$192K	0.14%	196
2022 Q3	$12.5M	Buy	643,792 +315,114	+96%	+$6.52M	0.14%	196
2022 Q2	$6.53M	Buy	328,678 +12,495	+4%	+$330K	0.07%	219
2022 Q1	$9.43M	Sell	316,183 -10,107	-3%	-$296K	0.08%	214
2021 Q4	$7.6M	Buy	326,290 +67,909	+26%	+$1.81M	0.06%	230
2021 Q3	$8.06M	Buy	258,381 +45,477	+21%	+$1.41M	0.07%	226
2021 Q2	$7.49M	Sell	212,904 -3,730	-2%	-$121K	0.07%	239
2021 Q1	$7.64M	Buy	216,634 +11,408	+6%	+$421K	0.07%	230
2020 Q4	$7.7M	Buy	205,226 +52,771	+35%	+$1.92M	0.08%	232
2020 Q3	$5.09M	Buy	+152,455	New	+$4.44M	0.07%	241

Other funds holding ALBO

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GW&K Investment Management's ALBO Position: Q2 2023 in Review

GW&K Investment Management sold out of Albireo Pharma Inc (ALBO) in Q2 2023, closing a stake of 1,080 shares — an estimated $48K sold.

GW&K Investment Management first reported a position in ALBO in Q3 2020 and held it in 11 quarters. The position peaked at $13.7M in Q4 2022. 1 fund tracked by Wall St. Rank holds ALBO as of Q2 2023.

GW&K Investment Management reported no remaining Albireo Pharma Inc position as of Q2 2023 after selling out during the quarter.
GW&K Investment Management sold 1,080 Albireo Pharma Inc shares in Q2 2023, an estimated $48K.
GW&K Investment Management first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 11 quarters.
GW&K Investment Management's Albireo Pharma Inc position peaked at $13.7M in Q4 2022.
1 fund tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2023.

Based on GW&K Investment Management's 13F filing for Q2 2023, filed 9 Aug 2023.